These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 16962565)

  • 1. Low affinity binding of the classical D1 antagonist SCH23390 in rodent brain: potential interaction with A2A and D2-like receptors.
    Leonard SK; Ferry-Leeper P; Mailman RB
    Brain Res; 2006 Oct; 1117(1):25-37. PubMed ID: 16962565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catalepsy induced by a blockade of dopamine D1 or D2 receptors was reversed by a concomitant blockade of adenosine A(2A) receptors in the caudate-putamen of rats.
    Hauber W; Neuscheler P; Nagel J; Müller CE
    Eur J Neurosci; 2001 Oct; 14(8):1287-93. PubMed ID: 11703457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Link between dopamine D1 and D2 receptors in rat and human striatal tissues.
    Seeman P; Tallerico T
    Synapse; 2003 Mar; 47(4):250-4. PubMed ID: 12539197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine A
    Real JI; Simões AP; Cunha RA; Ferreira SG; Rial D
    Eur J Neurosci; 2018 May; 47(9):1127-1134. PubMed ID: 29570875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors.
    Perachon S; Schwartz JC; Sokoloff P
    Eur J Pharmacol; 1999 Feb; 366(2-3):293-300. PubMed ID: 10082211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the characteristics and density of dopamine-1 receptors in membranes from different arteries using [3H]SCH23390 binding.
    Jin XH; Wang WZ; Zhao RR
    Methods Find Exp Clin Pharmacol; 1995 Sep; 17(7):455-61. PubMed ID: 8577207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The "selective" dopamine D1 receptor antagonist, SCH23390, is a potent and high efficacy agonist at cloned human serotonin2C receptors.
    Millan MJ; Newman-Tancredi A; Quentric Y; Cussac D
    Psychopharmacology (Berl); 2001 Jun; 156(1):58-62. PubMed ID: 11465634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of dopamine receptors in insect (Apis mellifera) brain.
    Kokay IC; Mercer AR
    Brain Res; 1996 Jan; 706(1):47-56. PubMed ID: 8720491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain.
    Sóvágó J; Makkai B; Gulyás B; Hall H
    Eur J Neurosci; 2005 Jul; 22(1):65-71. PubMed ID: 16029196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CB1 receptor knockout mice display reduced ethanol-induced conditioned place preference and increased striatal dopamine D2 receptors.
    Houchi H; Babovic D; Pierrefiche O; Ledent C; Daoust M; Naassila M
    Neuropsychopharmacology; 2005 Feb; 30(2):339-49. PubMed ID: 15383833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural determinants of pharmacological specificity between D(1) and D(2) dopamine receptors.
    Lan H; Durand CJ; Teeter MM; Neve KA
    Mol Pharmacol; 2006 Jan; 69(1):185-94. PubMed ID: 16236817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiparkinson therapeutic potencies correlate with their affinities at dopamine D2(High) receptors.
    Seeman P
    Synapse; 2007 Dec; 61(12):1013-8. PubMed ID: 17853435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatum.
    Hess EJ; Battaglia G; Norman AB; Iorio LC; Creese I
    Eur J Pharmacol; 1986 Feb; 121(1):31-8. PubMed ID: 2869957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
    Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
    J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative biochemical pharmacology of central nervous system dopamine D1 and D2 receptors.
    Reader TA; Molina-Holgado E; Dewar KM
    Mol Neurobiol; 1992; 6(4):425-50. PubMed ID: 1285933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased affinity of dopamine for D(2) -like versus D(1) -like receptors. Relevance for volume transmission in interpreting PET findings.
    Marcellino D; Kehr J; Agnati LF; Fuxe K
    Synapse; 2012 Mar; 66(3):196-203. PubMed ID: 22034017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D1 and D2 receptor selectivities of phenyl-benzazepines in rhesus monkey striata.
    Weed MR; Woolverton WL; Paul IA
    Eur J Pharmacol; 1998 Nov; 361(1):129-42. PubMed ID: 9851550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subunit-specific modulation of [(3)H]MK-801 binding to NMDA receptors mediated by dopamine receptor ligands in rodent brain.
    Wigestrand MB; Fonnum F; Ivar Walaas S
    Neurochem Int; 2012 Jul; 61(2):266-76. PubMed ID: 22561101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the bovine striatal D2 receptor, but not the D1 receptor, in bovine adrenal medulla.
    Maroto R; López MG; del Valle M; Naranjo JR; Mellström B; García AG
    Mol Pharmacol; 1995 Jan; 47(1):40-50. PubMed ID: 7838132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.